"13 November 2014 ¦ GENEVA - WHO warned today that progress towards the elimination of measles has stalled. The number of deaths from measles increased from an estimated 122 000 in 2012 to 145 700 in 2013, according to new data publish"...
Patients should be counseled that antibacterial drugs including ERY-TAB (erythromycin delayed release tablets) should only be used to treat bacterial infections. They do not treat viral infections (e.g., the common cold). When ERY-TAB (erythromycin delayed release tablets) is prescribed to treat a bacterial infection, patients should be told that although it is common to feel better early in the course of therapy, the medication should be taken exactly as directed. Skipping doses or not completing the full course of therapy may (1) decrease the effectiveness of the immediate treatment and (2) increase the likelihood that bacteria will develop resistance and will not be treatable by ERY-TAB (erythromycin delayed release tablets) or other antibacterial drugs in the future.
Last reviewed on RxList: 9/10/2008
This monograph has been modified to include the generic and brand name in many instances.
Additional Ery-Tab Information
Ery-Tab - User Reviews
Ery-Tab User Reviews
Now you can gain knowledge and insight about a drug treatment with Patient Discussions.
Report Problems to the Food and Drug Administration
You are encouraged to report negative side effects of prescription drugs to the FDA. Visit the FDA MedWatch website or call 1-800-FDA-1088.
Find out what women really need.